Literature DB >> 28939973

Sodium Channelopathies of Skeletal Muscle.

Stephen C Cannon1.   

Abstract

The NaV1.4 sodium channel is highly expressed in skeletal muscle, where it carries almost all of the inward Na+ current that generates the action potential, but is not present at significant levels in other tissues. Consequently, mutations of SCN4A encoding NaV1.4 produce pure skeletal muscle phenotypes that now include six allelic disorders: sodium channel myotonia, paramyotonia congenita, hyperkalemic periodic paralysis, hypokalemic periodic paralysis, congenital myasthenia, and congenital myopathy with hypotonia. Mutation-specific alternations of NaV1.4 function explain the mechanistic basis for the diverse phenotypes and identify opportunities for strategic intervention to modify the burden of disease.

Entities:  

Keywords:  Channelopathy; Gating pore; Myotonia; NaV1.4; Periodic paralysis; Sodium channel

Mesh:

Substances:

Year:  2018        PMID: 28939973      PMCID: PMC5866235          DOI: 10.1007/164_2017_52

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  91 in total

1.  Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis.

Authors:  L J Hayward; R H Brown; S C Cannon
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

2.  The role of chloride transport in the control of the membrane potential in skeletal muscle--theory and experiment.

Authors:  Jill Gallaher; Martin Bier; Jan Siegenbeek van Heukelom
Journal:  Biophys Chem       Date:  2009-03-25       Impact factor: 2.352

3.  Impaired slow inactivation in mutant sodium channels.

Authors:  T R Cummins; F J Sigworth
Journal:  Biophys J       Date:  1996-07       Impact factor: 4.033

4.  Interaction between fast and slow inactivation in Skm1 sodium channels.

Authors:  D E Featherstone; J E Richmond; P C Ruben
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

5.  Structural parts involved in activation and inactivation of the sodium channel.

Authors:  W Stühmer; F Conti; H Suzuki; X D Wang; M Noda; N Yahagi; H Kubo; S Numa
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

6.  The cloning and expression of a sodium channel beta 1-subunit cDNA from human brain.

Authors:  A I McClatchey; S C Cannon; S A Slaugenhaupt; J F Gusella
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

7.  Gating pore current in an inherited ion channelopathy.

Authors:  Stanislav Sokolov; Todd Scheuer; William A Catterall
Journal:  Nature       Date:  2007-03-01       Impact factor: 49.962

8.  Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH.

Authors:  F Lehmann-Horn; G Küther; K Ricker; P Grafe; K Ballanyi; R Rüdel
Journal:  Muscle Nerve       Date:  1987-05       Impact factor: 3.217

9.  Na+,K+-pump stimulation improves contractility in isolated muscles of mice with hyperkalemic periodic paralysis.

Authors:  Torben Clausen; Ole Bækgaard Nielsen; Johannes D Clausen; Thomas Holm Pedersen; Lawrence J Hayward
Journal:  J Gen Physiol       Date:  2011-07       Impact factor: 4.086

10.  Correlating phenotype and genotype in the periodic paralyses.

Authors:  T M Miller; M R Dias da Silva; H A Miller; H Kwiecinski; J R Mendell; R Tawil; P McManis; R C Griggs; C Angelini; S Servidei; J Petajan; M C Dalakas; L P W Ranum; Y H Fu; L J Ptácek
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

View more
  37 in total

Review 1.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

Review 2.  Central Role of Subthreshold Currents in Myotonia.

Authors:  Sabrina Metzger; Chris Dupont; Andrew A Voss; Mark M Rich
Journal:  Ann Neurol       Date:  2019-11-27       Impact factor: 10.422

3.  Voltage-dependent Ca2+ release is impaired in hypokalemic periodic paralysis caused by CaV1.1-R528H but not by NaV1.4-R669H.

Authors:  Marino DiFranco; Stephen C Cannon
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-27       Impact factor: 5.282

4.  Functional analysis of three Nav1.6 mutations causing early infantile epileptic encephalopathy.

Authors:  Laura Solé; Jacy L Wagnon; Michael M Tamkun
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-08       Impact factor: 5.187

5.  Homozygous C-terminal loss-of-function NaV1.4 variant in a patient with congenital myasthenic syndrome.

Authors:  Andoni Echaniz-Laguna; Valérie Biancalana; Aleksandra Nadaj-Pakleza; Emmanuel Fournier; Emma Matthews; Michael G Hanna; Roope Männikkö
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-06-02       Impact factor: 10.154

Review 6.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

7.  Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes.

Authors:  Po Wei Kang; Nourdine Chakouri; Johanna Diaz; Gordon F Tomaselli; David T Yue; Manu Ben-Johny
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

8.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

9.  PharmGKB summary: very important pharmacogene information for CACNA1S.

Authors:  Katrin Sangkuhl; Robert T Dirksen; Maria L Alvarellos; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

Review 10.  Molecular and cellular basis of genetically inherited skeletal muscle disorders.

Authors:  James J Dowling; Conrad C Weihl; Melissa J Spencer
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-13       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.